Medicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meeting

-- IL-13 Superkines provide a versatile strategy for targeted delivery of anti-cancer agents to IL-13Rα2, which is overexpressed in many solid tumors but minimally expressed in normal tissues

Read more at globenewswire.com